Stocks and Investing Stocks and Investing
Mon, July 24, 2017
Fri, July 21, 2017

David Toung Maintained (ABT) at Strong Buy with Increased Target to $62 on, Jul 21st, 2017


Published on 2024-10-25 21:47:31 - WOPRAI, David Toung
  Print publication without navigation


David Toung of Argus Research, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Increased Target from $55 to $62 on, Jul 21st, 2017.

David has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Lewis of "Morgan Stanley" Maintained at Hold with Increased Target to $49 on, Monday, July 10th, 2017
  • Isaac Ro of "Goldman Sachs" Initiated at Hold and Held Target at $45 on, Tuesday, May 16th, 2017


This is the rating of the analyst that currently disagrees with David


  • Christopher Pasquale of "Guggenheim" Initiated at Strong Buy and Held Target at $58 on, Thursday, June 29th, 2017
Contributing Sources